Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|107|9|1338-1344

ISSN： 1347-9032

Source： Cancer Science, Vol.107, Iss.9, 2016-09, pp. : 1338-1344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL‐17A‐producing CD30+ Vδ1 T cells drive inflammation‐induced cancer progression

By  

Cancer Science, Vol. 107, Iss. 9, 2016-09 ,pp. : 1206-1214

John Wiley & Sons Inc

Access to resources Recommend Favorite

STX11 functions as a novel tumor suppressor gene in peripheral T‐cell lymphomas

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1455-1462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human T‐cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T‐cells

By  

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 461-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advanced human T‐cell leukemia virus type 1 carriers and early‐stage indolent adult T‐cell leukemia‐lymphoma are indistinguishable based on CADM1 positivity in flow cytometry

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 598-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of desmoid tumor progression using miRNA expression profiling

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 650-655

John Wiley & Sons Inc

Access to resources Recommend Favorite